ADVANCED BREAST CANCER
Clinical trials for ADVANCED BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets advanced breast cancer in early trial
Disease control Not yet recruitingThis study tests a combination of two experimental drugs, AK146D1 and AK112, in 200 people with advanced HER2-negative breast cancer that cannot be removed by surgery. The main goals are to check safety and see if the treatment shrinks tumors. This is a Phase 2 trial, meaning it …
Matched conditions: ADVANCED BREAST CANCER
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated May 26, 2026 06:08 UTC
-
New hope for advanced breast cancer: drug combo enters human testing
Disease control Not yet recruitingThis study tests a new combination of two drugs (camizestrant and atirmociclib) in 24 people with a specific type of advanced breast cancer (ER-positive, HER2-negative) that has worsened after previous treatment. The main goal is to check safety and how the body processes the dru…
Matched conditions: ADVANCED BREAST CANCER
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 06:02 UTC
-
New pill combo shows promise for Hard-to-Treat breast cancer
Disease control Not yet recruitingThis study tests a new tablet called QLC1401 combined with standard cancer drugs (CDK4/6 or mTOR inhibitors) in people with ER+/HER2- advanced or metastatic breast cancer. The goal is to find a safe dose and see if the combination shrinks tumors. About 96 participants will join t…
Matched conditions: ADVANCED BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New hope for advanced breast cancer: experimental combo enters phase II
Disease control Not yet recruitingThis study tests a new drug combination (SYS6023 plus other treatments) in people with advanced breast cancer that cannot be removed by surgery or has spread. The goal is to find the best dose, check safety, and see if the combination shrinks tumors. About 114 adults with a speci…
Matched conditions: ADVANCED BREAST CANCER
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New drug delivery methods tested for tough breast cancer
Disease control Not yet recruitingThis study is for people with HER2-positive advanced breast cancer. It tests a drug called SHR-A1811 given in different ways (like injection or infusion) to see which works best and is safest. About 60 adults who have had up to 2 prior treatments will take part. The goal is to sh…
Matched conditions: ADVANCED BREAST CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Could a device help control advanced breast cancer?
Disease control Not yet recruitingThis study tests a device called TheraBionic P1 in 82 people with advanced or metastatic HR-positive, HER2-negative breast cancer who have already tried standard hormone therapies. The goal is to see if the device can slow cancer growth and improve survival. Participants will use…
Matched conditions: ADVANCED BREAST CANCER
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Personalized diet may boost Well-Being in advanced cancer patients
Symptom relief Not yet recruitingThis study tests whether a personalized diet plan can improve quality of life for 100 women with advanced gynecologic or breast cancer who are already receiving antibody-drug conjugate (ADC) therapy. Participants are randomly assigned to either a tailored diet or general Mediterr…
Matched conditions: ADVANCED BREAST CANCER
Phase: PHASE2 • Sponsor: TNC Nutrición Terapéutica S.L. • Aim: Symptom relief
Last updated May 26, 2026 06:11 UTC